8-K filing — Nexalin Technology, Inc. (NXL)
Filed: 2026-10-01 AccNo: 0001829126-26-010686 Size: 191 KB Item 8.01: Other Events
Stocks · News reference
Nexalin shares are trading lower. The company reported exploratory ADAS-Cog data from its completed trial of the Gen-2 SYNC DIFS neurostimulation device in in mild Alzheimer’s disease.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Nasdaq Gains 100 Points; ISM manufacturing PMI Slips In September
U.S. stocks edged higher Thursday; Nasdaq rose 0.37%, energy led gains, Accenture surged 18%, and Corteva plunged 84%.
Why Is Nexalin Technology Stock Gaining Thursday?
Nexalin Technology (NXL) stock surged 80% on massive volume following a 10-year South American distribution and manufacturing deal.
Dow Falls Over 200 Points; Micron Earnings Top Views
U.S. stocks slipped Thursday as the Dow fell over 200 points; energy and oil rose, Micron beat estimates, and European markets declined.